Characterization of WY 14,643 and its complex with Aldose reductase
dc.contributor.author | Sawaya, M.R. | |
dc.contributor.author | Verma, M. | |
dc.contributor.author | Balendiran, V. | |
dc.contributor.author | Rath, N.P. | |
dc.contributor.author | Cascio, D. | |
dc.contributor.author | Balendiran, G.K. | |
dc.date.accessioned | 2018-01-05T06:18:13Z | |
dc.date.accessioned | 2024-08-13T10:34:05Z | |
dc.date.available | 2018-01-05T06:18:13Z | |
dc.date.available | 2024-08-13T10:34:05Z | |
dc.date.issued | 2016 | |
dc.date.issued | 2016 | |
dc.description.abstract | The peroxisome proliferator, WY 14,643 exhibits a pure non-competitive inhibition pattern in the aldehyde reduction and in alcohol oxidation activities of human Aldose reductase (hAR). Fluorescence emission measurements of the equilibrium dissociation constants, Kd, of oxidized (hAR? NADP+) and reduced (hAR? NADPH) holoenzyme complexes display a 2-fold difference between them. Kd values for the dissociation of WY 14,643 from the oxidized (hAR? NADP+ ? WY 14,643) and reduced (hAR? NADPH? WY 14,643) ternary complexes are comparable to each other. The ternary complex structure of hAR? NADP+ ? WY 14,643 reveals the first structural evidence of a fibrate class drug binding to hAR. These observations demonstrate how fibrate molecules such as WY 14,643, besides being valued as agonists for PPAR, also inhibit hAR. ? The Author(s) 2016. | en_US |
dc.identifier.citation | Sawaya, M. R., Verma, M., Balendiran, V., Rath, N. P., Cascio, D., & Balendiran, G. K. (2016). Characterization of WY 14,643 and its complex with Aldose reductase. Scientific Reports, 6. doi: 10.1038/srep34394 | en_US |
dc.identifier.doi | 10.1038/srep34394 | |
dc.identifier.issn | Online- 2045-2322 | |
dc.identifier.issn | 20452322 | |
dc.identifier.uri | https://kr.cup.edu.in/handle/32116/489 | |
dc.identifier.url | https://www.nature.com/articles/srep34394 | |
dc.language.iso | en | en_US |
dc.publisher | Nature Publishing Group | en_US |
dc.subject | Aldehyde Reductase | en_US |
dc.subject | Holoenzyme | en_US |
dc.subject | Nicotinamide Adenine Dinucleotide Phosphate | en_US |
dc.subject | Pirinixic Acid | en_US |
dc.subject | Pyrimidine Derivative | en_US |
dc.subject | Chemistry | en_US |
dc.subject | Human | en_US |
dc.subject | Protein Domain | en_US |
dc.subject | Aldehyde Reductase | en_US |
dc.subject | Holoenzymes | en_US |
dc.subject | Humans | en_US |
dc.subject | Nadp | en_US |
dc.subject | Protein Domains | en_US |
dc.subject | Pyrimidines | en_US |
dc.title | Characterization of WY 14,643 and its complex with Aldose reductase | en_US |
dc.title.journal | Scientific Reports | |
dc.type | Article | en_US |